Heavy and light forms of elongation factor 1 (EF-1) from calf brain have been partially purified. The heterogeneous heavy species (EF-1H) with molecular weights of 2.5 X 105 to over 1 X 106 appears to be a complex or aggregate of the light form of the enzyme (EF-IL); the latter has a molecular weight of between 50,000 and 60,000. EF-1H but not EF-IL, contains significant amounts of free and esterified cholesterol. Although EF-1 and EF-IL are both active in aminoacyl-tRNA binding to ribosomes, EF-IL reacts with GTP and aminoacyl-tRNA more efficiently than EF-1H.
We have described studies on the interactions of elongation factor 1 (EF-1) from calf brain with guanosine nucleotides and aminoacyl-tRNA (1, 2). Evidence was first obtained with a nitrocellulose filter assay that an aminoacyl-tRNA EF-1 GTP ternary complex could be formed since EF-1 * GTP was retained on the filter in the absence but not in the presence of aminoacyl-tRNA (1). More recent experiments with Sephadex G-150 chromatography (2) provided further evidence for ternary complex formation. These results also suggested that different forms of EF-1 were involved in these interactions, and that a low-molecular-weight species of the enzyme appeared to be part of the ternary complex. The interaction of the ternary complex with calf-brain ribosomes has also been demonstrated (3) , and data in support of the view that the ternary complex contains a form of EF-1 having a molecular weight of less than 100,000 have been obtained.
Multiple forms of EF-1 have been demonstrated in other mammalian tissues (4, 5) and wheat (6) , although their nature and function are not clear. The present study describes the partial purification of EF-1 from calf brain and the separation of heavy and light forms of the enzyme. The characteristics of these EF-1 species were examined.
MATERIALS AND METHODS
Purification of EF-1 from Calf Brain. A typical purification started with 10 calf brains. Each brain (about 450 g) was homogenized in a Waring Blender for 20 see in 100 ml of a buffer containing 50 mM Tris HCl (pH 7.4)-25 mM KCl-5 mM MgCl2-0.25 M sucrose. The homogenate was centrifuged for 10 min at 5000 rpm in a Sorvall GSA rotor and then for 30 min at 9000 rpm.
(NH4)2SO4 Fractionation. 16 .4 g of solid (NH4)2SO4 was added to each 100 ml of the post mitochondrial fraction. After 30 min the solution was centrifuged for 30 min at 9000 rpm in a Sorvall GSA rotor. The precipitate was discarded, and 21.4 g of solid (NH4)2SO4 was added to each 100 ml of the supernatant. After 30 min of stirring, the solution was centrifuged.
The pellet was dissolved in a small volume of buffer containing 50 mM Tris* HCl (pH 7.4)-i mM dithiothreitol (buffer A) and dialyzed against the same buffer. After dialysis, the A280 of the sample was adjusted to 35-40 per ml.
Calcium Phosphate
Step. To the dialyzed (NH4)2SO4 fraction we added 0.7 volume of a 3% calcium phosphate suspension (Calbiochem. Corp.). After 1 hr of stirring, the suspension was centrifuged for 5 min at 5000 rpm in a Sorvall GSA rotor. The supernatant was discarded and the pellet was extracted with 0.7 volume of 30% saturated (NH4)2SO4. After centrifugation the first extraction was saved and the pellet was again extracted with 0.5 volume of 30% saturated (NH4)2SO4. The two extracts were combined, and the proteins were precipitated by addition of solid (NH4)2SO4 to 75% saturation. The precipitate was dissolved in a small volume of buffer A and dialyzed against the same buffer. The calcium phosphate pellet, after the two extractions with 30% saturated (NH4)2SO4, was saved for preparation of the heavy-molecular-weight forms of the enzyme (EF-1H).
Sepharose 6B
Step. Sepharose 6B (Pharmacia Fine Chemical Corp.) was packed in a column (5 X 90 cm) and equilibrated with buffer A. 60 ml of the (NH4)2SO4 extract from the calcium phosphate step (about 3 g of protein) was placed on the column, and 20-ml fractions were collected. The EF-1 activity eluted as a broad band between fractions 30 and 60. The fractions containing EF-1 were combined and concentrated by precipitation with 75% saturated (NH4)2SO4. The concentrated Sepharose 6B fraction was dialyzed against 0.01 M potassium phosphate buffer (pH 7.0) containing 1 mM dithiothreitol (buffer B).
Hydroxylapatite
Step. A hydroxylapatite column (Clarkson Chemical Corp.) (2.5 X 30 cm) was equilibrated with buffer B. The Sepharose fraction containing 800-1000 mg of protein was placed on the column, and the column was eluted with 1000 ml of a linear gradient of 0.01-0.5 AI potassium phosphate buffer (pH 7.0) containing 1 mM dithiothreitol. 10-ml Fractions were collected, and the EF-1 activity was eluted between 0.25 and 0.4 M potassium phosphate. 10 Confirmation of the presence of cholesterol and identification of other lipids present in the enzyme were done by various chromatographic techniques. In general, 500 units of EF-1 (0.3-1 ml) were added to chloroform-methanol (1: 2 by volume) to make a homogeneous solution. Equal volumes of' chloroform and water were then added. The tubes were mixed on a Vortex mixer and centrifuged. The lower layer was removed and evaporated to dryness; the residue was dissolved in 50,gl of ether. Neutral lipids and phospholipids were separated on I.T.L.C. type paper (Gelman Co.) with isooctaneisopropanol acetate (100: 3) and CHC13-CH30H-NH40H (100: 9: 1) as solvents, respectively. The compounds were detected with a 50% H2SO4 spray.
Cholesterol and cholesterol esters were also separated on silica gel thin-layer plates (Schwarz/Mann), with a chloroform-methanol solvent (98:2 by volume). To locate cholesterol and cholesterol esters, we sprayed the air-dried plates with a solution of chloroform saturated with SbCl3 and heated at 750 for 20 min (9) . Cholesterol (RF = 0.46) and cholesterol esters (RF = 0.66) appeared as pink spots. For identification of the fatty acids present in the cholesterol esters, the cholesterol ester region of the thin-layer plates (located by iodine vapor) was scraped off and eluted with 2 ml of methanol. 0.5 ml of 33% KOH was added and the solution was heated at 550 for 20 min. After it was cooled, the solution was acidified with HCl and extracted with hexane. The hexane was evaporated to dryness and the residue was transferred with three 100-,l aliquots of methanol to 1-ml reactivials (Pierce Chem. Co.).
The methanol was evaporated, and to each vial were added 15 ,l of methanol and about 0.3 ml of an ethereal solution of diazomethane. After 5 min, the solution was evaporated to dryness and the residue was dissolved in 25 ,l of methanol. chromatograph equipped with a hydrogen flame ionization detector. A 6-foot (1.83-m), 3% SE-30 (80/100 Gas Chrom Q) column was used (initial temperature 1600).
Authentic cholesterol 14-methylhexadecanoate was prepared from cholesterol acetate and methyl 14-methyl hexadecanoate in the presence of sodium methoxide (10).
Assay for EF-1 Activity and Reaction of EF-1 with GTP and Aminoacyl-tRNA. The assay for EF-1 activity was based on the ability of EF-1 to stimulate Phe-tRNA binding to calfbrain ribosomes (3) . The reaction of EF-1 with GTP to form an EF-1 -GTP complex that is retained on a nitrocellulose filter was performed as described (1). The reaction of the EF-1 * GTP complex with Phe-tRNA to form a Phe-tRNA EF-1 *GTP complex that is not retained on a nitrocellulose filter has also been described (1). All radioactive determinations were made with an LS-100 Beckman scintillation counter with a water-miscible scintillation fluid (11) .
RESULTS
Preparation of EF-1. In these studies two different preparations of EF-1 were studied, EF-1H and EF-iL. Table 1 summarizes a typical purification of the two forms of EF-1. Specific activities as high as 1200-1400 units/mg of protein have been obtained for both EF-1H and EF-iL, although values of 700-1000 are routinely achieved. Sucrose gradient analysis showed that EF-1H is heterogeneous and contains several species of different molecular weight with EF-1 activity, although the EF-1L appears to be more homogeneous with respect to EF-1 activity. Previous studies (1, 2) used EF-1 preparations that contained a mixture of EF-1H and EF-IL.
Sucrose Gradient Profiles of EF-1. The post-mitochondrial supernatant, after centrifugation through a 5-20% sucrose gradient, showed a heterogeneous distribution of EF-1 activity (Fig. 1) . Prominent species having molecular weights ranging from 6 X 104 to > 1 X 106 were observed. By the purification procedure described above, it was possible to obtain enriched fractions of the heavy and light species (Fig. 1) . A large part of the EF-1H fraction contained species with molecular weights above 5 X 105, although some enzyme activity with molecular weights in the 2 to 3 X 105 range was generally present in these fractions. The EF-1L fraction contained one major peak of EF-1 activity (showing some asymmetry) with the peak fraction having a calculated molecular weight of slightly less than 6 X 104. It was noted during the purification that there was a tendency for the heavier forms of the enzyme to break down to lighter species, which accounted for the heterogeneous nature of EF-1H and indicated that the heavier forms were aggregates of a low-molecular-weight species.
Gel Electrophoresis of EF-1 Preparations. Polyacrylamide gel electrophoresis of the EF-1H and EF-1L forms are seen in Fig. 2 . The heavy form of the enzyme was prepared as described in Methods and then further purified by sucrose gradient centrifugation (Fig. 1) . The peak fractions containing EF-1 of molecular weight > 1 X 106 were combined and subjected to electrophoresis with a 5.2% gel at pH 8.6 (gel A). A major protein band was seen which did not enter the gel. Duplicate gels were sliced and eluted (5) molecular weight 50,000-60,000 that is similar to EF-1L (gels.
B and D and Fig. 1 ).
Lipid Components in EF-1. Hradec and coworkers (13) have reported that partially purified EF-1 preparations from rat liver and human tonsils contain a cholesterol ester, i.e., cholesterol 14-methylhexadecanoic acid. They also reported that cholesterol-14 methylhexadecanoic acid is essential for EF-1 activity. A similar observation was made by this group in their studies on aminoacyl-tRNA synthetases (14) . From these earlier reports, it seemed possible that cholesterol or cholesterol esters could be part of the high-molecular-weight aggregates of EF-1H. acid (32% of total), and palmitoleic acid (17% of total). There was no evidence of significant amounts of 14-methylhexadecanoic acid in the cholesterol esters.
Interaction of Various EF-1 Preparations with Guanosine Nucleotides and Aminoacyl-tRNA. Having separated two distinct fractions of EF-1 (EF-1H and EF-1L), it was now possible for us to examine how these EF-1 forms varied in their reactivity. Although both functioned in aminoacyltRNA binding to ribosomes and amino-acid polymerization, Table  1 and then further fractionated by sucrose gradient centrifugation (Fig. 1) . The peak fractions were used for the gel analysis. * Formation of the ternary complex was determined by the ability of Phe-tRNA to cause EF-1 to pass through a nitrocellulose filter (1).
we observed that the EF-1H and EF-1L reacted quite differently with guanosine nucleotides and aminoacyl-tRNA. The ratio of nucleotide binding per unit of EF-1 activity was lower with EF-lH than with EF-1L (Table 3 ). In most cases the values of pmol of GTP bound/unit of EF-1 approached 1 with the EF-iL preparation, whereas values of less than 0.30 were routinely seen with the EF-1H preparation.
Previous studies (1, 3) demonstrated that EF-1 GTP reacts with aminoacyl-tRNA to form a ternary complex, aminoacyl-tRNA -EF-1 . GTP, which is not retained by a nitrocellulose filter. This reaction can be measured indirectly by determining the loss of nucleotide retention on the filter in the presence of aminoacyl-tRNA or more directly by the appearance of EF-1 activity in the filtrate. Table 3 also shows the results of incubating the various EF-1 preparations with GTP and aminoacyl-tRNA. With the EF-1H preparation, generally 10-20% of the EF-1 participated in ternary complex formation, whereas 50-60% or more of the EF-iL preparations could react with aminoacyl-tRNA. Recently, similar results have been obtained with a partially purified preparation of EF-1 from wheat germ, i.e., the high-molecular-weight form of the enzyme reacts much more poorly with GTP and aminoacyl-tRNA than with the low-molecular-weight species (6) .
DISCUSSION
The present results indicate that the high-molecular-weight species of EF-1 are aggregates of a low-molecular-weight form of between 50,000 and 60,000 ( Figs. 1 and 2 ). It appears that the basic unit of EF-1H is similar to EF-1L, although until both proteins are purified and characterized more carefully, this conclusion must be considered tentative. We can now summarize the characteristics of EF-1H and EF-1L: Both species are quite active in aminoacyl-tRNA binding to ribosomes. The stability of EF-1H is considerably greater than that of EF-1L, and although EF-1H is not sensitive to sulfhydryl reagents, EF-1L was inhibited more than 60% by 0.1 mM N-ethylmaleimide (unpublished observations). EF-1L, compared to EF-1H, appears to react much better with GTP and GTP plus aminoacyl-tRNA to form the corresponding complexes, which is very likely a reflection of the greater stability of the complexes containing EF-iL. Cholesterol and cholesterol esters are also present in EF-1H but not EF-1L. In general, EF-1L behaves very much like EF-Tu from prokaryote systems in both its reactivity and general properties. Because of the lability of EF-1L, as well as the fact that the major species of EF-1 in brain are high-molecular-weight aggregates, EF-1H is the form of the enzyme that is routinely purified. Based on our current knowledge, it appears that EF-1H (>200,000 molecular weight) is the predominant species that has been purified from liver (4, 5) and reticulocytes (15) by other workers.
One of the most interesting aspects of the present study concerns the presence of free cholesterol and cholesterol esters in the EF-1H preparations. Hradec and coworkers (13) first reported that EF-1 preparations contained a unique cholesterol ester (cholesterol-14-methylhexadecanoate) which was also present in a complex of aminoacyl-tRNA synthetases (14) . A similar result on the presence of cholesterol in a eukaryote aminoacyl-tRNA synthetase preparation has been reported by Bandyopadhyay and Deutscher (16) . All of these observations suggest that cholesterol or cholesterol esters may play an important role in the formation and stability of highmolecular-weight complexes in eukaryote systems. We have no evidence of a single predominant fatty acid present in the EF-1H preparation, but larger quantities of highly purified preparations of EF-1H are needed before a more definitive identification can be made of the fatty acids present. It will also be important to compare EF-1H from various tissues with regard to lipid content. Cholesterol-14 methylhexadecanoate was not found in the EF-1 preparations from calf brain, and preliminary attempts on our -part to activate EF-1H preparations that have been extracted with organic solvents as described by Hradec et al. (13) have been unsuccessful. We do not know whether EF-1H merely represents a storage form of EF-1L, a high-molecular-weight regulatory complex, or an artifact of the isolation procedure. The latter seems unlikely since EF-1H preparations have been found in all of the eukaryote systems examined, regardless of the purification procedures used.
Previous results with calf-brain EF-1 and wheat EF-1 have demonstrated that EF-1L is the form of EF-1 that is present in the aminoacyl-tRNA-EF-1 GTP complex (2, 3, 6) , although EF-1H can react with GTP. Fig. 4 summarizes our current thoughts on the interaction of EF-1 from calf brain. EF-1H is apparently a high-molecular-weight complex containing cholesterol, cholesterol esters, and other unidentified components. It can react with GTP to form an EF-1H* GTP complex (2) . The reaction of this complex with aminoacyltRNA yields a ternary complex containing the light species of EF-1 (2, 3) . This complex reacts with the ribosomal-mRNA complex with transfer of the aminoacyl-tRNA to the ribosomes (3). The latter reaction involves GTP hydrolysis, and indirect evidence has been obtained that EF-1L GTP is formed (2, 3) . The recycling of EF-1 has not been clarified. EF-1L* GDP could be converted directly to EF-1L* GTP which can react with aminoacyl-tRNA, or the EF-1L GDP may aggregate and react with GTP to form EF-1H* GTP in
